The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by surprise.